VKH
IBRX icon

Virtu KCG Holdings’s ImmunityBio IBRX Stock Holding History

Virtu KCG Holdings’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$183K Buy
+24,151
New +$104K 0.01% 2198
2017
Q1 		– Sell
-16,369
Closed -$94K – 3403
2016
Q4 		$94K Buy
16,369
+2,189
+15% +$14.6K ﹤0.01% 2933
2016
Q3 		$110K Buy
+14,180
New +$106K ﹤0.01% 2607

Other funds holding IBRX

WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return

Virtu KCG Holdings's IBRX Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in ImmunityBio (IBRX) in Q2 2017: 24,151 shares worth $183K. The stake represents 0.01% of the portfolio and ranks #2198 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in IBRX as recently as Q4 2016.

Virtu KCG Holdings first reported a position in IBRX in Q3 2016 and has held it in 3 quarters since. 58 funds tracked by Wall St. Rank hold IBRX as of Q2 2017.

  • Virtu KCG Holdings held 24,151 shares of ImmunityBio worth $183K as of Q2 2017.
  • ImmunityBio was a new Virtu KCG Holdings position in Q2 2017.
  • ImmunityBio made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2198 holding.
  • Virtu KCG Holdings first reported a position in ImmunityBio in Q3 2016 and has held it in 3 quarters since.
  • 58 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.